REGENXBIO, Inc. (RGNX)
5.72
-0.52
(-8.41%)
USD |
NASDAQ |
May 15, 16:00
5.83
+0.11
(+1.92%)
Pre-Market: 20:00
REGENXBIO Shareholders Equity (Quarterly) : 21.08M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.505B |
| Ocugen, Inc. | 5.805M |
| Replimune Group, Inc. | 210.54M |
| AbbVie, Inc. | -6.656B |
| Krystal Biotech, Inc. | 1.277B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 341.89M |
| Total Liabilities (Quarterly) | 320.81M |
| Debt to Equity Ratio | 11.78 |
| Current Ratio | 2.623 |
| Net Debt Paydown Yield | -4.93% |